Clinical course and outcome of patients with ACTH-dependent Cushing's syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations.
Zhanna BelayaOlga GolouninaGalina MelnichenkoNatalia TarbaevaEvgenia PashkovaMaxim GorokhovViktor KalashnikovLarisa DzeranovaValentin FadeevPavel VolchkovIvan DedovPublished in: Endocrine (2021)
The outcome of COVID-19 in patients with CS depends on the severity of hypercortisolism. Thus, severe hypercortisolism is a warning sign that CS affected by COVID-19 could require emergency care despite a lack of clinical presentations and low inflammation biomarkers.